Trial Profile
An observational, retrospective study comparing primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Oct 2018
Price :
$35
*
At a glance
- Drugs Itraconazole (Primary) ; Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Mycoses
- Focus Therapeutic Use
- 25 Oct 2018 New trial record